Sapreme Technologies BV
PrivateLast Round
Series A
Oct 7, 2021
Total Funding Raised
$25.01M
Company Overview
Sapreme Technologies BV is a biotechnology company that develops a proprietary endosomal escape platform to enable the cytosolic delivery of macromolecule therapeutics for genetically driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sapreme Technologies BV Comparables
Compare Sapreme Technologies BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 86% | |
| Libera Bio | 81% | |
| NanoSyrinx | 80% |
Sapreme Technologies BV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2021 | ||||
| Grant | Feb 20, 2019 | ||||
| Seed | Jan 1, 2016 |
Key People
Founding team and executive leadership
Sapreme Technologies BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union | Grant |
| East Netherlands Development Agency (Oost NL) | Series A |
| Aglaia Oncology Funds | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2021
$17.3M round led by Aglaia Oncology Funds
- Feb 20, 2019
Received $8M from the European Union.
Sapreme Technologies BV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sapreme Technologies BV's valuation, stock price, and market status.
Is Sapreme Technologies BV a public or private company?
Sapreme Technologies BV is a private company.
What is the current stock price of Sapreme Technologies BV?
Sapreme Technologies BV is a private company with no public stock price. No recent secondary market data is available.
How much is Sapreme Technologies BV worth (valuation)?
Valuation information for Sapreme Technologies BV is not publicly available.
Can I buy Sapreme Technologies BV stock?
Sapreme Technologies BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sapreme Technologies BV's last funding round?
Sapreme Technologies BV's most recent funding round was Series A on October 7, 2021.
Who are the main investors in Sapreme Technologies BV?
Key investors in Sapreme Technologies BV include Aglaia Oncology Funds.
Will Sapreme Technologies BV IPO soon?
No public IPO plans have been announced for Sapreme Technologies BV.
How can I track Sapreme Technologies BV secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sapreme Technologies BV's secondary market activity and sign up for updates.